Costagliola Giorgio, De Marco Emanuela, Massei Francesco, Roberti Giulia, Catena Fabrizio, Casazza Gabriella, Consolini Rita
Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, 56126, Italy.
Pediatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy.
Ther Clin Risk Manag. 2024 May 16;20:261-274. doi: 10.2147/TCRM.S462996. eCollection 2024.
Lymphoproliferation is defined by lymphadenopathy, splenomegaly, hepatomegaly, or lymphocytic organ and tissue infiltration. The most common etiologies of lymphoproliferation are represented by infectious diseases and lymphoid malignancies. However, it is increasingly recognized that lymphoproliferative features can be the presenting sign of rare conditions, including inborn errors of immunity (IEI) and inborn errors of metabolism (IEM). Among IEI, lymphoproliferation is frequently observed in autoimmune lymphoproliferative syndrome (ALPS) and related disorders, common variable immunodeficiency (CVID), activated phosphoinositide 3-kinase δ syndrome, and Epstein-Barr virus (EBV)-related disorders. Gaucher disease and Niemann-Pick disease are the most common IEMs that can present with isolated lymphoproliferative features. Notably, other rare conditions, such as sarcoidosis, Castleman disease, systemic autoimmune diseases, and autoinflammatory disorders, should be considered in the differential diagnosis of patients with persistent lymphoproliferation when infectious and malignant diseases have been reasonably ruled out. The clinical features of lymphoproliferative diseases, as well as the associated clinical findings and data deriving from imaging and first-level laboratory investigations, could significantly help in providing the correct diagnostic suspicion for the underlying etiology. This paper reviews the most relevant diseases associated with lymphoproliferation, including infectious diseases, hematological malignancies, IEI, and IEM. Moreover, some practical indications to orient the initial diagnostic process are provided, and two diagnostic algorithms are proposed for the first-level assessment and the approach to persistent lymphoproliferation, respectively.
淋巴细胞增殖的定义为淋巴结病、脾肿大、肝肿大或淋巴细胞器官及组织浸润。淋巴细胞增殖最常见的病因是传染病和淋巴系统恶性肿瘤。然而,人们越来越认识到,淋巴细胞增殖特征可能是包括先天性免疫缺陷(IEI)和先天性代谢缺陷(IEM)在内的罕见疾病的首发症状。在IEI中,淋巴细胞增殖在自身免疫性淋巴细胞增殖综合征(ALPS)及相关疾病、常见变异型免疫缺陷(CVID)、活化磷脂酰肌醇3激酶δ综合征以及爱泼斯坦-巴尔病毒(EBV)相关疾病中经常出现。戈谢病和尼曼-匹克病是最常见的可表现为孤立性淋巴细胞增殖特征的IEM。值得注意的是,在合理排除感染性和恶性疾病后,对于持续性淋巴细胞增殖患者进行鉴别诊断时,应考虑其他罕见疾病,如结节病、卡斯尔曼病、系统性自身免疫性疾病和自身炎症性疾病。淋巴细胞增殖性疾病的临床特征以及相关的临床发现和影像学及一级实验室检查数据,有助于对潜在病因提供正确的诊断怀疑。本文综述了与淋巴细胞增殖相关的最相关疾病,包括传染病、血液系统恶性肿瘤、IEI和IEM。此外,还提供了一些指导初始诊断过程的实用建议,并分别针对一级评估和持续性淋巴细胞增殖的处理提出了两种诊断算法。